We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu
Trial record 32 of 40 for:    herbal medicine AND Chinese | Recruiting, Not yet recruiting, Available Studies

Pilot Study on Traditional Chinese Medicine and Food Allergy (TCMFA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02490813
Recruitment Status : Recruiting
First Posted : July 7, 2015
Last Update Posted : January 17, 2018
Chinese University of Hong Kong
Information provided by (Responsible Party):
Hong Kong Sanatorium & Hospital

Brief Summary:

Recently, there has been an increasing interest in using traditional Chinese medicine for food allergy. The Harvard group has successfully demonstrated the Food Allergy Herbal Formula - FAHF2 completely blocked peanut-induced anaphylaxis in a murine model, and currently being studied in human. Therefore, in collaboration with the Institute of Chinese Medicine, CUHK, the investigators have developed a more simplified Chinese herbal formula - X (CHFX), containing four food-grade Chinese herbs, Wu-mei (Fructus Pruni Mume); Ling-zhi (Gonoderma); Huang-bai (Cortex Phellodendron) and Zhi-su (Perilla frutescens).

In the present study, the investigators would like to examine whether there is reduction in allergic symptoms in food challenge after administering the CHFX for 8 weeks. There will be pre- and post- CHFX food challenges and other related tests.

Condition or disease Intervention/treatment
Allergy to Fish Allergy to Shrimp Allergy to Crab Dietary Supplement: Treatment - Chinese Herbal Formula - X Dietary Supplement: Placebo

Detailed Description:

The investigators aim to recruit 24 subjects for the present study. Subjects will be randomized into two groups, control group (n=12) and treatment group (n=12). At recruitment all subjects will be required to stop anti-allergic medicines and Chinese medicines as a wash out period for two weeks (week 1 and week 2). They will be required to keep a record of their symptoms and peak flow rates twice daily throughout the entire study. Skin prick test will be performed with a panel of commercially available skin test solutions for cod, shrimp and crab (ALK). Total and specific IgE as well as total and specific IgG4 for fish and shellfish will be measured (by the HKSH laboratory or CUHK laboratory). Graded open cod, shrimp or crab challenge will be performed as described later at HKSH in each patient to determine the baseline tolerance level to fish or shellfish, using freeze-dried cod, shrimp or crab as appropriate.

After determining the baseline tolerance level, subjects in the treatment group will take 2 grams of the CHFX or placebo daily for 8 weeks (week 4 to week 11). The placebo powder consists of food grade medicinal starch blended with coloring agent. After the 8 weeks of treatment, skin prick tests, blood tests as at baseline and oral challenges will be repeated (week 12). During the study subjects will be requested to consume their normal diet but avoiding fish and shellfish, with no consumption of any other Chinese herbal medication. They can take anti-allergic medicines as necessary but will note when medicines are taken in their symptom and peak flow diary.

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 24 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Care Provider)
Primary Purpose: Treatment
Official Title: Pilot Study on Traditional Chinese Medicine and Food Allergy
Study Start Date : August 2015
Estimated Primary Completion Date : August 2018
Estimated Study Completion Date : August 2018

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arm Intervention/treatment
Placebo Comparator: Control
This arm will receive the placebo.
Dietary Supplement: Placebo
Placebo will be starch with colorings
Experimental: Treatment - Chinese Herbal Formula - X
This arm will receive the Chinese Herbal Formula - CHFX as treatment to their existing fish, shrimp or crab allergy.
Dietary Supplement: Treatment - Chinese Herbal Formula - X
Wu Mei (Fructus Pruni Mume), Ling Zhi (Gonoderma), Huang Bai (Cortex Phellodendron), and Zhi Su (Perilla frutescens).

Primary Outcome Measures :
  1. Tolerance to existing allergen [ Time Frame: 8 weeks ]
    subjects will be accessed on tolerance to existing allergen via opened oral food challenge

Secondary Outcome Measures :
  1. Skin prick test result [ Time Frame: 8 weeks ]
    Skin prick test result to existing allergen

  2. Blood test - IgE result [ Time Frame: 8 weeks ]
    Specific IgE test result to existing allergen

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   8 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Age 8 years or older with a history of allergic reaction to cod, shrimp or crab, manifested by any of the following: urticaria, angioedema, asthma or anaphylaxis, within 60 mins of ingestion.
  • Having a positive skin prick test to the cod, shrimp or crab as defined by a weal diameter 3 mm greater than the diluent control.
  • Having a positive oral challenge with freeze-dried cod, shrimp or crab.
  • Asthma must be under control with a FEV1 of at least 80% predicted value.
  • Aspirin, anti-histamines/anti-allergic medicines and antidepressants are not permitted for 3 days, one week and two weeks, respectively, before skin testing or oral food challenge.

Exclusion Criteria:

  • Pregnancy.
  • Requiring systemic glucocorticoids, beta-blockers and ACE inhibitors.
  • Having poorly controlled asthma, poorly controlled atopic dermatitis prior to study.
  • Inability to discontinue antihistamines or other medication for skin testing and oral challenges.
  • Unable to comply with the study protocol for any reason.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02490813

Contact: June Chan, Master 2835-8430 junechan@hksh.com
Contact: Tak Hong Lee, Doctor 2835-8430 thlee@hksh.com

Hong Kong
Hong Kong Sanatorium & Hospital Recruiting
Happy Valley, Hong Kong
Contact: JUNE CHAN, MASTER    +85228358430    junechan@hksh.com   
Contact: TAK LEE, DOCTOR    +85228358430    thlee@hksh.com   
Sponsors and Collaborators
Hong Kong Sanatorium & Hospital
Chinese University of Hong Kong
Principal Investigator: June Chan, Master Hong Kong Sanatorium & Hospital

Responsible Party: Hong Kong Sanatorium & Hospital
ClinicalTrials.gov Identifier: NCT02490813     History of Changes
Other Study ID Numbers: ALC-002
First Posted: July 7, 2015    Key Record Dates
Last Update Posted: January 17, 2018
Last Verified: January 2018

Keywords provided by Hong Kong Sanatorium & Hospital:
Fish allergy
shrimp allergy
crab allergy
traditional Chinese medicine

Additional relevant MeSH terms:
Food Hypersensitivity
Immune System Diseases
Hypersensitivity, Immediate